Hydrogen Nanotherapy in Lab Tests Against Colorectal Cancer
Nanobiocatalyst-Driven Spatiotemporal Hydrogen Delivery Induces Dormancy Potentiated Catalytic Tumor Therapy
Research hubs: Digestive System · Immune System
This research was done on cells or tissue in a lab, not in people or animals.
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Zhiyue Cao, Rui Xin, Qiuyue Ma, Qinghui Wang, Shuaiyang Feng, Huiyu Su, Ayang Zhao, Kai Li, Shujuan Liu, Liangcan He, Shaoqin Liu
- Journal
- ACS Nano
- Year
- 2025
- PMID
- 40931918
- Study Type
- Cell Culture
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 15 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
A light-activated nanoparticle released hydrogen and 5-ASA to push colorectal tumors into dormancy and make them more vulnerable to oxidative destruction.
Key Finding
A platinum-based nanomaterial that generates hydrogen gas and releases 5-aminosalicylic acid suppressed colorectal cancer cells in laboratory cultures by inducing dormancy (cell cycle arrest) while simultaneously blocking tumor-protective signaling pathways.
Summary
Researchers created a tiny engineered material containing platinum that generates hydrogen gas when exposed to light and releases a drug called 5-aminosalicylic acid. In laboratory cell cultures of colorectal cancer, this combination worked through two mechanisms: the hydrogen gas put cancer cells into a dormant (inactive) state by disrupting their energy balance, while the drug blocked a protein called NF-κB that helps tumors survive. Together, these actions stopped cancer cells from dividing and made them vulnerable to damage.
Practical Takeaway
This is very early-stage laboratory research using engineered nanomaterials and cell cultures, not human studies or even animal testing. While it provides mechanistic evidence that hydrogen gas may contribute to cancer cell suppression, it is far too preliminary to draw any conclusions about hydrogen water's effects on human cancer. Significant development and clinical testing would be needed before any therapeutic application.
Abstract (excerpt)
Colorectal cancer remains a therapeutic challenge due to systemic toxicity and the suboptimal efficacy of conventional therapies. Emerging evidence indicates that molecular hydrogen (H2) exerts antitumor effects through proliferation suppression and induction of a "tumor dormancy" phenotype…